Supreme Court asked to pause ruling blocking telehealth and mail access to abortion pills

Danco Laboratories, one of the makers of the abortion pill mifepristone, asked the Supreme Court on Saturday to block a lower court ruling that imposed a nationwide requirement for the medication to be dispensed in person.In its filing, the drugmaker also asked the high court to grant an immediate pause of the lower court’s ruling while the Supreme Court considers the appeal.“Danco has been free to rely on the procedures set by FDA to distribute its product. The Fifth Circuit’s decision immediately ends that. A stay should issue to prevent the disruption and confusion that will result if the decision below were to remain operative,” lawyers for the company wrote in their filing.02:05The 5th Circuit U.S. Court of Appeals on Friday night granted the state of Louisiana’s request to reinstate an old requirement for abortion pills to be dispensed in person. That ruling was a win for anti-abortion activists because it bans the distribution of abortion pills via telehealth or mail.Distributing mifepristone by mail has been a key way for women who live in states with abortion bans to access abortion care since the Supreme Court overturned Roe v. Wade in 2022.In a statement, Planned Parenthood Action Fund President and